| Literature DB >> 30205735 |
Xuebin Hu1, Zhaojing Lu1, Shanshan Yu1, James Reilly2, Fei Liu1, Danna Jia1, Yayun Qin1, Shanshan Han, Xiliang Liu1, Zhen Qu1, Yuexia Lv1, Jingzhen Li1, Yuwen Huang1, Tao Jiang1, Haibo Jia1, Qing Wang1, Jingyu Liu1, Xinhua Shu2, Zhaohui Tang1, Mugen Liu1.
Abstract
Macroautophagy/autophagy is an important intracellular mechanism for the maintenance of cellular homeostasis. Here we show that the CERKL (ceramide kinase like) gene, a retinal degeneration (RD) pathogenic gene, plays a critical role in regulating autophagy by stabilizing SIRT1. In vitro and in vivo, suppressing CERKL results in impaired autophagy. SIRT1 is one of the main regulators of acetylation/deacetylation in autophagy. In CERKL-depleted retinas and cells, SIRT1 is downregulated. ATG5 and ATG7, 2 essential components of autophagy, show a higher degree of acetylation in CERKL-depleted cells. Overexpression of SIRT1 rescues autophagy in CERKL-depleted cells, whereas CERKL loses its function of regulating autophagy in SIRT1-depleted cells, and overexpression of CERKL upregulates SIRT1. Finally, we show that CERKL directly interacts with SIRT1, and may regulate its phosphorylation at Ser27 to stabilize SIRT1. These results show that CERKL is an important regulator of autophagy and it plays this role by stabilizing the deacetylase SIRT1.Entities:
Keywords: Autophagy; CERKL; SIRT1; deacetylation; retinitis pigmentosa; stabilization
Year: 2018 PMID: 30205735 PMCID: PMC6351130 DOI: 10.1080/15548627.2018.1520548
Source DB: PubMed Journal: Autophagy ISSN: 1554-8627 Impact factor: 16.016
Figure 1.Autophagy flux was impaired in cerkl retinas. (a) Immunoblotting of Lc3 and Sqstm1 in retinal extracts from wild-type (WT) and cerkl zebrafish aged 1 month. (b) Immunostaining analysis of Lc3 in retinas of WT and cerkl zebrafish aged 1 month. Scale bars: 10 μm. INL, inner nuclear layer; ONL, outer nuclear layer; IS, inner segments. (c) Immunostaining analysis of Lc3 in RPE of WT and cerkl zebrafish aged 1 month. Scale bars: 10 μm.
Figure 2.Autophagy was impaired in CERKL-depleted ARPE-19 cells. (a) Immunoblotting analysis of LC3 and SQSTM1 in negative control (NC) and CERKL-depleted ARPE-19 cells. (b and c) Immunoblotting and quantification of the levels of endogenous LC3-II:LC3-I ratio in NC and CERKL-depleted ARPE-19 cells post treatment with DMSO and 100 nM rapamycin for 2 h. Means± SEM of 5 repeats are shown. (d and e) Immunoblotting and quantification of the levels of endogenous LC3-II:LC3-I ratio in NC and CERKL-depleted ARPE-19 cells under normal and serum starvation (SS) condition for 1, 2 and 4 h. Means± SEM of 5 repeats are shown. (f) Immunostaining analysis of LC3 in NC and CERKL-depleted ARPE-19 cells induced by siRNA under normal and SS condition for 1 h. Scale bars: 10 μm. (g) Immunostaining of the distribution of exogenous GFP-LC3 in NC and CERKL-depleted ARPE-19 cells under normal and SS condition for 1 h. Scale bars: 10 μm.
Figure 3.Autophagic flux was impaired in CERKL-depleted ARPE-19 cells. (a and b) Immunoblotting and quantification of the levels of endogenous LC3-II:LC3-I ratio in negative control (NC) and CERKL-depleted ARPE-19 cells under DMSO and 2.5 nM bafilomycin A1 condition for 3 h. Means± SEM of 5 repeats are shown. (c) Immunostaining analysis of the colocalization GFP-LC3 and RFP-LAMP1 in NC and CERKL-depleted ARPE-19 cells. Scale bars: 10 μm.
Figure 4.CERKL did not directly interact with the components of autophagosomes. (a) Immunostaining analysis of endogenous LC3B or exogenous GFP-LC3 and FLAG-CERKL in ARPE-19 cells. Scale bars: 5 μm. (b) Immunoblotting of the autophagy proteins ATG5 and ATG7 in NC and CERKL-depleted ARPE-19 cells. (c) Immunoblotting of the upstream regulator proteins of autophagy in NC and CERKL-depleted ARPE-19 cells. (d) Quantification of proteins presented in panels B and C. Relative expression of proteins in relation to TUBA. Means± SEM of 5 repeats are shown.
Figure 5.CERKL affected autophagy via SIRT1. (a and b) Immunostaining and quantification of the protein levels of SIRT1 in negative control (NC) and CERKL-depleted ARPE-19 cells. Relative expression of proteins in relation to TUBA. Means± SEM of 5 repeats are shown. (c and d) Immunostaining and quantification of the protein levels of Sirt1 in retinal extracts from wild-type (WT) and cerkl zebrafish aged 1 month. Relative expression of Sirt1 in relation to Tuba. Means± SEM of 4 repeats are shown, each sample contain eyeballs of 4 zebrafish. (e) Immunoblotting of the levels of endogenous LC3-II:LC3-I ratio under a gradient expression of exogenous FLAG-SIRT1 in NC and CERKL-depleted ARPE-19 cells. Each well was transfected with 0.5 μg FLAG-SIRT1 plasmid in lane 2 and 4, 1 μg in lane 5, and 2 μg in lane 6.
Figure 6.Acetylation analysis in CERKL-depleted ARPE-19 cells. (a) ARPE-19 cell extracts transfected with NC and siCERKL immunoprecipitated (IP) with pan acetyl-lysine antibody and analyzed with ATG5 and ATG7 antibodies. Input, whole cell extracts. (b) Quantification of proteins presented in panel A. Relative expression of proteins in relation to TUBA. Means± SEM of 5 repeats are shown.
Figure 7.CERKL regulated the stability of SIRT1. (a) SIRT1 protein levels at indicated times post treatment with 200 μg/ml cycloheximide (CHX) in negative control (NC) and CERKL-depleted ARPE-19 cells. (b) Quantification of protein presented in panel A. Relative expression of SIRT1 in relation to GAPDH. Means± SEM of 3 repeats are shown. (c and d) Immunostaining and quantification of the protein levels of SIRT1 p-S27 and p-S47 in NC and CERKL-depleted ARPE-19 cells. Relative expression of proteins in relation to TUBA. Means± SEM of 5 repeats are shown.
Figure 8.Overexpressing CERKL stabilized SIRT1. (a and b) Immunostaining and quantification of the protein levels of SIRT1 p-S27 and p-S47 in ARPE-19 cells overexpressing GFP and GFP-CERKL. Relative expression of proteins in relation to TUBA. Means± SEM of 5 repeats are shown. (c and d) SIRT1 protein levels at the indicated times post treatment with 300 μg/ml CHX in ARPE-19 cells overexpressing GFP and GFP-CERKL. Relative expression of SIRT1 in relation to GAPDH. Means± SEM of 3 repeats are shown. (e) Immunostaining analysis of LC3 and SQSTM1 in ARPE-19 cells overexpressing GFP and GFP-CERKL. (f) Immunostaining of the distribution of LC3 in ARPE-19 cells overexpressing GFP and GFP-CERKL. Scale bars: 10 μm.
Figure 9.CERKL directly interacted with SIRT1. (a and b) Reciprocal co-immunoprecipitation assays. ARPE-19 cell extracts transfected with plasmids encoding GFP-CERKL and FLAG-SIRT1 were immunoprecipitated with one indicated tag antibody (FLAG in A, and GFP in B) and analyzed by immunoblotting analysis with the other antibody. (c) Immunostaining analysis of the colocalization of CERKL and SIRT1 in ARPE-19 cells transfected with plasmids encoding GFP-CERKL (green) and FLAG-SIRT1 (red). Scale bars: 10 μm. (d) ARPE-19 cell extracts from cells transfected with plasmids encoding GFP-CERKL and FLAG-SIRT1 were immunoprecipitated with GFP antibody and analyzed by immunoblotting analysis with FLAG antibody and SIRT1 p-S27 antibody. (e) ARPE-19 cell extracts from cells transfected with plasmids encoding GFP-CERKL and wild-type or mutant forms of FLAG-SIRT1 were immunoprecipitated with GFP and analyzed by immunoblotting analysis with FLAG antibody.
Table List of primary antibodies used in this study.
| Antibodies | Source | Recognize | Dilution |
|---|---|---|---|
| Anti-LC3B | Abcam Ab48394 | Zebrafish and human LC3B | 1:1000 for WB |
| Anti-CERKL | Sigma-Aldrich HPA035444 | Human CERKL | 1:1000 for WB |
| Anti-SQSTM1/p62 | ABclonal A7758 | Human SQSTM1 | 1:1000 for WB |
| Anti-ATG5 | ABclonal A7252 | Human ATG5 | 1:1000 for WB |
| Anti-ATG7 | ABclonal A0691 | Human ATG7 | 1:1000 for WB |
| Anti-SIRT1 | ABclonal A11267 | Zebrafish and human SIRT1 | 1:700 for WB |
| Proteintech 13161-1-AP | Zebrafish and human SIRT1 | 1:700 for WB | |
| Anti-phospho-SIRT1 (Ser27) | Cell Signaling Technology 2327 | Human SIRT1 p-S27 | 1:500 for WB |
| Anti-phospho-SIRT1 (Ser47) | Cell Signaling Technology 2314 | Human SIRT1 p-S47 | 1:200 for WB |
| Anti-pan acetyl-lysine | ABclonal A2391 | 1 mg per 1 ml cell lysate for IP | |
| Anti-AMPK | ABclonal A1229 | Human AMPKα | 1:1000 for WB |
| Anti-AMPK p-T172 | ABclonal AP0116 | Human phospho-PRKAA/AMPKα p-T172 | 1:1000 for WB |
| Anti-BECN1/BECLIN1 | Proteintech 11306-1-AP | Human BECN1 | 1:700 for WB |
| Anti-TUBA/α-TUBULIN | Proteintech 11224-1-AP | Zebrafish and human TUBA | 1:5000 for WB |
| Anti-GADPH | ABclonal AC027 | Human GAPDH | 1:3000 for WB |
| Anti-FLAG | MBL M185-3L | FLAG | 1:5000 for WB |
| Anti-GFP | Absmart | GFP | 1:5000 for WB |
| Proteintech 50430-2-AP | GFP | 1 mg per 1 ml cell lysate for IP |